General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations

+1 862 778 7336

Novartis Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

This site is not intended for U.S. residents.
Research & Development

Accelerating development

of medicines with potential

for greater patient benefit

Open

Research & Development

 

Together, we explore novel compounds in clinical development, many with potential best-in-class status, aiming to advance or create new
standards of care.

Pipeline

See compounds in all phases of development, from preclinical studies through large, randomized Phase III trials.
Explore our interactive pipeline

Clinical Trials

Novartis is currently conducting clinical trials in a number of disease areas. Learn more